SEQUANA MEDICAL NV (SEQUA.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:SEQUA - BE0974340722 - Common Stock
0.584 EUR
+0.02 (+2.64%)
SEQUA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. SEQUA may be in some trouble as it scores bad on both profitability and health. SEQUA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year SEQUA has reported negative net income.
- SEQUA had a negative operating cash flow in the past year.
- SEQUA had negative earnings in each of the past 5 years.
- In the past 5 years SEQUA always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -355.86%, SEQUA is not doing good in the industry: 94.03% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -355.86% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-296.55%
ROA(5y)-236.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SEQUA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, SEQUA has more shares outstanding
- SEQUA has more shares outstanding than it did 5 years ago.
- SEQUA has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -31.39, we must say that SEQUA is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -31.39, SEQUA is not doing good in the industry: 89.55% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -31.39 |
ROIC/WACCN/A
WACC5.84%
2.3 Liquidity
- A Current Ratio of 0.20 indicates that SEQUA may have some problems paying its short term obligations.
- The Current ratio of SEQUA (0.20) is worse than 94.03% of its industry peers.
- SEQUA has a Quick Ratio of 0.20. This is a bad value and indicates that SEQUA is not financially healthy enough and could expect problems in meeting its short term obligations.
- SEQUA has a worse Quick ratio (0.16) than 92.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.2 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
- SEQUA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.31%.
- SEQUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
- The Revenue for SEQUA have been decreasing by -35.84% on average. This is quite bad
EPS 1Y (TTM)-32.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.99%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%
3.2 Future
- Based on estimates for the next years, SEQUA will show a very strong growth in Earnings Per Share. The EPS will grow by 26.42% on average per year.
- Based on estimates for the next years, SEQUA will show a very strong growth in Revenue. The Revenue will grow by 462.98% on average per year.
EPS Next Y81.63%
EPS Next 2Y32.86%
EPS Next 3Y26.42%
EPS Next 5YN/A
Revenue Next Year782.35%
Revenue Next 2Y689.05%
Revenue Next 3Y462.98%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- SEQUA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year SEQUA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- SEQUA's earnings are expected to grow with 26.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.86%
EPS Next 3Y26.42%
5. Dividend
5.1 Amount
- No dividends for SEQUA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SEQUANA MEDICAL NV / SEQUA.BR FAQ
What is the fundamental rating for SEQUA stock?
ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR.
What is the valuation status for SEQUA stock?
ChartMill assigns a valuation rating of 1 / 10 to SEQUANA MEDICAL NV (SEQUA.BR). This can be considered as Overvalued.
How profitable is SEQUANA MEDICAL NV (SEQUA.BR) stock?
SEQUANA MEDICAL NV (SEQUA.BR) has a profitability rating of 0 / 10.